PharmaCielo Ltd.
PCLOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 275.3% | -57% | -51.1% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -30.3% | 4% | 15% | 42.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -27.3% | -135.4% | -138.4% | -37.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -111.9% | -403.4% | -286.6% | -133.3% |
| EPS Diluted | -0.005 | -0.005 | -0.009 | -0.009 |
| % Growth | -3.9% | 43.3% | -4.7% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |